Ms Drug
Ampyra [am-PEER-ah], the brand name for a new drug named fampridine-SR, has been approved by the US Food and Drug Administration for the treatment of Multiple Sclerosis. The new drug is the first Multiple Sclerosis drug to enhance some neurological functioning for MS patients. Dr. Andrew Goodman, chief of the University of Rochester Medical Center’s […]
Continue reading about Ampyra, A New Multiple Sclerosis Drug with Promise
MSNBC.com has a piece this morning about the Multiple Sclerosis drug Tysabri® (natalizumab). The drugmakers have issued warnings to doctors because Tysabri is causing significant liver damage to some patients who take it. In some patients the damage occurred as early as six days after beginning the treatment. MSNBC.com : Multiple sclerosis drug linked to […]